TG Therapeutics | TGTX - Devedores Comerciais





Devedores Comerciais Alterar Data
AbbVie USD 12.48B 110M 2026-03
Alaunos Therapeutics USD 2K 0 2025-06
Amgen USD 10.23B 1.09B 2026-06
Ardelyx USD 82.84M 10.99M 2026-03
Arrowhead Research USD 8.56M 7.13M 2026-06
Bayer EUR 18.7B 146M 2026-06
Biogen USD 1.79B 76.6M 2026-03
Corcept Therapeutics USD 76.92M 37.85M 2026-06
Curis USD 2.55M 400K 2024-06
Gilead Sciences USD 5.06B 314M 2026-06
J&J USD 22.54B 1.21B 2026-03
Karyopharm Therapeutics USD 23.36M 2.82M 2026-03
Novartis USD 9.85B 252M 2026-06
Novavax USD 106.45M 72.27M 2025-12
PTC Therapeutics USD 219.92M 38.3M 2026-03
Puma Biotechnology USD 28.1M 3.52M 2024-06
Regeneron Pharmaceuticals USD 6.57B 834.4M 2026-06
Roche Holding CHF 13.34B 1.44B 2026-06
TG Therapeutics USD 401.56M 9.52M 2026-06
Verastem USD 10.36M 1.34M 2026-03
Vertex Pharmaceuticals USD 2.13B 138.2M 2026-06